Instil Bio Inc Revenue Growth Rates (TIL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Instil Bio Inc   (NASDAQ: TIL)
 

TIL's Revenue Growth by Quarter and Year

Instil Bio Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TIL/growth
https://api.csimarket.com/api/v1/companies/TIL/fundamentals
https://api.csimarket.com/api/v1/companies/TIL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
TIL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 2.24
1st Quarter March 2.24
FY 4.48





TIL Revenue second quarter 2026 Y/Y Growth Comment
Instil Bio Inc reported Revenue growth of 0.09% year on year in the second quarter 2026, to $ 2.24 millions, this is lower than Instil Bio Inc 's recent average Revenue surge of 349079.41%.

Looking into second quarter 2026 results within Biotechnology & Pharmaceuticals industry 44 other companies have achieved higher Revenue growth. While Instil Bio Inc ' s Revenue increase of 0.09% ranks overall at the positon no. 2873 in the second quarter 2026.


TIL Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.09 %
1st Quarter March 0 %
FY   -

Financial Statements
Instil Bio Inc 's second quarter 2026 Revenue $ 2.24 millions TIL's Income Statement
Instil Bio Inc 's second quarter 2025 Revenue $ 2.24 millions Quarterly TIL's Income Statement


TIL Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.09 %
1st Quarter March 0 %
FY (Year on Year)   -


Back to TIL Growth rate Comparisons >> Back to TIL Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #45
Healthcare Sector #401
Overall #2873

Revenue Y/Y Growth Statistics
High Average Low
3840354.55 % 349079.41 % -100 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #45
Healthcare Sector #401
Overall #2873
Revenue Y/Y Growth Statistics
High Average Low
3840354.55 % 349079.41 % -100 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Instil Bio Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
7008990.91 % 438058.21 % -100 %
(Jun 30 2016)  


TIL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Instil Bio Inc disclosed growth in Revenue from the first quarter by 0.09% to $ 2.24 millions, from $ 2.24 millions achived in the previous reporting period.

Within Biotechnology & Pharmaceuticals industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Instil Bio Inc 's Revenue growth quarter on quarter, overall rank is 1822.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #33
Healthcare Sector #239
Overall #1822
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #33
Healthcare Sector #239
Overall #1822
Revenue Q/Q Growth Statistics
High Average Low
7008990.91 % 438058.21 % -100 %
(Jun 30 2016)  


TIL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Instil Bio Inc disclosed growth in Revenue from the first quarter by 0.09% to $ 2.24 millions, from $ 2.24 millions achived in the previous reporting period.

Within Biotechnology & Pharmaceuticals industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Instil Bio Inc 's Revenue growth quarter on quarter, overall rank is 1822.


Instil Bio Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 8.97
Y / Y Revenue Growth (TTM) 2.48 %
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) 0 %
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
With 2.48% annual Revenue growth, Instil Bio Inc would report a record annual Revenue improvement if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 340 other companies have achieved higher trailing twelve month Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 39
Healthcare Sector # 341
Overall # 2377

Revenue TTM Y/Y Growth Statistics
High Average Low
2.48 %
 -26.95 %
-56.39 %
(Jun 30 2026)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 267
S&P 500 # 1688
Cumulative Revenue growth Comment
With 2.48% annual Revenue growth, Instil Bio Inc would report a record annual Revenue improvement if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 340 other companies have achieved higher trailing twelve month Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 39
Healthcare Sector # 341
Overall # 2377

Revenue TTM Y/Y Growth Statistics
High Average Low
2.48 %
-26.95 %
-56.39 %
(Jun 30 2026)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 33
Sector # 267
S&P 500 # 1688




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TIL's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Ocular Therapeutix Inc 0.12%$ 0.119 millions


About Instil Bio Inc Revenue Growth Rates (TIL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.